ALZ-103

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALZ-103
Drug Alias NameALZ-103
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlzinova AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlzinova AB
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A